Stefanie S. Jeffrey, MD

Publications

• Multiplex molecular analysis of CTCs. Sieuwerts AM, Jeffrey SS. Recent Results Cancer Res. 2012: 195 125-40
• Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G, Telli ML, Advani RH, Carlson RW, Mollick JA, Sheth S, Kurian AW, Ford JM, Stockdale FE, Quake SR, Pease RF, Mindrinos MN, Bhanot G, Dairkee SH, Davis RW, Jeffrey SS. PLoS One. 2012; 7 (5): e33788
• A pharmacogenomic method for individualized prediction of drug sensitivity. Cohen AL, Soldi R, Zhang H, Gustafson AM, Wilcox R, Welm BE, Chang JT, Johnson E, Spira A, Jeffrey SS, Bild AH. Mol Syst Biol. 2011: 7 513
• Adipose levels of polybrominated diphenyl ethers and risk of breast cancer. Hurley S, Reynolds P, Goldberg D, Nelson DO, Jeffrey SS, Petreas M. Breast Cancer Res Treat. 2011; 129 (2): 505-11
• Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells. Luciani MG, Seok J, Sayeed A, Champion S, Goodson WH, Jeffrey SS, Xiao W, Mindrinos M, Davis RW, Dairkee SH. PLoS One. 2011; 6 (5): e20016
• Characterization of molecular subtypes of Korean breast cancer: an ethnically and clinically distinct population. Han W, Nicolau M, Noh DY, Jeffrey SS. Int J Oncol. 2010; 37 (1): 51-9
• Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. Ameri K, Luong R, Zhang H, Powell AA, Montgomery KD, Espinosa I, Bouley DM, Harris AL, Jeffrey SS. Br J Cancer. 2010; 102 (3): 561-9
• Focal amplification and oncogene dependency of GAB2 in breast cancer. Bocanegra M, Bergamaschi A, Kim YH, Miller MA, Rajput AB, Kao J, Langerød A, Han W, Noh DY, Jeffrey SS, Huntsman DG, Børresen-Dale AL, Pollack JR. Oncogene. 2010; 29 (5): 774-9
• Stem cells in human breast cancer. Oliveira LR, Jeffrey SS, Ribeiro-Silva A. Histol Histopathol. 2010; 25 (3): 371-85
• Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Talasaz AH, Powell AA, Huber DE, Berbee JG, Roh KH, Yu W, Xiao W, Davis MM, Pease RF, Mindrinos MN, Jeffrey SS, Davis RW. Proc Natl Acad Sci U S A. 2009; 106 (10): 3970-5
• Basal carcinoma of the breast revisited: an old entity with new interpretations. Korsching E, Jeffrey SS, Meinerz W, Decker T, Boecker W, Buerger H. J Clin Pathol. 2008; 61 (5): 553-60
• CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer. Bergamaschi A, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langerød A, Han W, Noh DY, Huntsman DG, Jeffrey SS, Børresen-Dale AL, Pollack JR. Mol Oncol. 2008; 2 (4): 327-39
• Cancer biomarker profiling with microRNAs. Jeffrey SS, Nat Biotechnol. 2008; 26 (4): 400-1
• DNA copy number alterations and expression of relevant genes in triple-negative breast cancer. Han W, Jung EM, Cho J, Lee JW, Hwang KT, Yang SJ, Kang JJ, Bae JY, Jeon YK, Park IA, Nicolau M, Jeffrey SS, Noh DY. Genes Chromosomes Cancer. 2008; 47 (6): 490-9
• Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Wang Y, Ikeda DM, Narasimhan B, Longacre TA, Bleicher RJ, Pal S, Jackman RJ, Jeffrey SS. Radiology. 2008; 246 (2): 367-75
• MRI-guided radiofrequency ablation of breast cancer: preliminary clinical experience. van den Bosch M, Daniel B, Rieke V, Butts-Pauly K, Kermit E, Jeffrey S. J Magn Reson Imaging. 2008; 27 (1): 204-8
• New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. Kohrt HE, Olshen RA, Bermas HR, Goodson WH, Wood DJ, Henry S, Rouse RV, Bailey L, Philben VJ, Dirbas FM, Dunn JJ, Johnson DL, Wapnir IL, Carlson RW, Stockdale FE, Hansen NM, Jeffrey SS. BMC Cancer. 2008: 8 66
• Disease-specific genomic analysis: identifying the signature of pathologic biology. Nicolau M, Tibshirani R, Børresen-Dale AL, Jeffrey SS. Bioinformatics. 2007; 23 (8): 957-65
• Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome. Dairkee SH, Nicolau M, Sayeed A, Champion S, Ji Y, Moore DH, Yong B, Meng Z, Jeffrey SS. Oncogene. 2007; 26 (43): 6269-79
• RNA extraction from ten year old formalin-fixed paraffin-embedded breast cancer samples: a comparison of column purification and magnetic bead-based technologies. Ribeiro-Silva A, Zhang H, Jeffrey SS. BMC Mol Biol. 2007: 8 118
• TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer. Langerød A, Zhao H, Borgan Ø, Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS. Breast Cancer Res. 2007; 9 (3): R30
• Transcriptomic signatures in breast cancer. Fu J, Jeffrey SS. Mol Biosyst. 2007; 3 (7): 466-72
• Cell trapping in activated micropores for functional analysis. Talasaz AH, Powell AA, Stahl P, Ronaghi M, Jeffrey SS, Mindrinos M, Davis RW. Conf Proc IEEE Eng Med Biol Soc. 2006: 1 1838-41
• Discovery and validation of breast cancer subtypes. Kapp AV, Jeffrey SS, Langerød A, Børresen-Dale AL, Han W, Noh DY, Bukholm IR, Nicolau M, Brown PO, Tibshirani R. BMC Genomics. 2006: 7 231
• Lysyl oxidase is essential for hypoxia-induced metastasis. Erler JT, Bennewith KL, Nicolau M, Dornhöfer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ. Nature. 2006; 440 (7088): 1222-6
• MRI-guided needle localization of suspicious breast lesions: results of a freehand technique. van den Bosch MA, Daniel BL, Pal S, Nowels KW, Birdwell RL, Jeffrey SS, Ikeda DM. Eur Radiol. 2006; 16 (8): 1811-7
• Radiation-induced effects on gene expression: an in vivo study on breast cancer. Helland A, Johnsen H, Frøyland C, Landmark HB, Saetersdal AB, Holmen MM, Gjertsen T, Nesland JM, Ottestad W, Jeffrey SS, Ottestad LO, Rodningen OK, Sherlock G, Børresen-Dale AL. Radiother Oncol. 2006; 80 (2): 230-5
• A streamlined platform for high-content functional proteomics of primary human specimens. Jessani N, Niessen S, Wei BQ, Nicolau M, Humphrey M, Ji Y, Han W, Noh DY, Yates JR, Jeffrey SS, Cravatt BF. Nat Methods. 2005; 2 (9): 691-7
• Adipose levels of dioxins and risk of breast cancer. Reynolds P, Hurley SE, Petreas M, Goldberg DE, Smith D, Gilliss D, Mahoney ME, Jeffrey SS. Cancer Causes Control. 2005; 16 (5): 525-35
• Genomics-based prognosis and therapeutic prediction in breast cancer. Jeffrey SS, Lønning PE, Hillner BE. J Natl Compr Canc Netw. 2005; 3 (3): 291-300
• MRI features of mucosa-associated lymphoid tissue lymphoma in the breast. Espinosa LA, Daniel BL, Jeffrey SS, Nowels KW, Ikeda DM. AJR Am J Roentgenol. 2005; 185 (1): 199-202
• Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization. Wallace AM, Daniel BL, Jeffrey SS, Birdwell RL, Nowels KW, Dirbas FM, Schraedley-Desmond P, Ikeda DM. J Am Coll Surg. 2005; 200 (4): 527-37
• Magnetic resonance imaging of suspicious breast masses seen on one mammographic view. Offodile RS, Daniel BL, Jeffrey SS, Wapnir I, Dirbas FM, Ikeda DM. Breast J. 2004 Sep-Oct; 10 (5): 416-22
• A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue. Dairkee SH, Ji Y, Ben Y, Moore DH, Meng Z, Jeffrey SS. BMC Genomics. 2004; 5 (1): 47
• Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale AL, Jeffrey SS. Mol Biol Cell. 2004; 15 (6): 2523-36
• Distribution of persistent, lipid-soluble chemicals in breast and abdominal adipose tissues: lessons learned from a breast cancer study. Petreas M, Smith D, Hurley S, Jeffrey SS, Gilliss D, Reynolds P. Cancer Epidemiol Biomarkers Prev. 2004; 13 (3): 416-24
• The evolution of accelerated, partial breast irradiation as a potential treatment option for women with newly diagnosed breast cancer considering breast conservation. Dirbas FM, Jeffrey SS, Goffinet DR. Cancer Biother Radiopharm. 2004; 19 (6): 673-705
• Predictors of reexcision findings and recurrence after breast conservation. Smitt MC, Nowels K, Carlson RW, Jeffrey SS. Int J Radiat Oncol Biol Phys. 2003; 57 (4): 979-85
• The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions. Jeffrey SS, Pollack JR. Breast Cancer Res. 2003; 5 (6): 320-8
• Expression array technology in the diagnosis and treatment of breast cancer. Jeffrey SS, Fero MJ, Børresen-Dale AL, Botstein D. Mol Interv. 2002; 2 (2): 101-9
• MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. Qayyum A, Birdwell RL, Daniel BL, Nowels KW, Jeffrey SS, Agoston TA, Herfkens RJ. AJR Am J Roentgenol. 2002; 178 (5): 1227-32
• Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Børresen-Dale AL, Brown PO. Proc Natl Acad Sci U S A. 2002; 99 (20): 12963-8
• Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis. Zhao H, Hastie T, Whitfield ML, Børresen-Dale AL, Jeffrey SS. BMC Genomics. 2002; 3 (1): 31
• Locally advanced breast cancer: is surgery necessary? Favret AM, Carlson RW, Goffinet DR, Jeffrey SS, Dirbas FM, Stockdale FE. Breast J. 2001 Mar-Apr; 7 (2): 131-7
• Breast cancer: variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy. Birdwell RL, Smith KL, Betts BJ, Ikeda DM, Strauss HW, Jeffrey SS. Radiology. 2001; 220 (1): 47-53
• Expedition inspiration consensus 2001. Benz CC, Hilakivi-Clarke L, Conzen S, Dorn RV, Fleming GF, Grant K, Greene G, Hellman S, Henderson C, Hoover R, Hryniuk W, Jeffrey S, Lippman M, Lung J, Mitchell M, Pike M. Breast Cancer Res Treat. 2001; 70 (3): 213-9
• Freehand iMRI-guided large-gauge core needle biopsy: a new minimally invasive technique for diagnosis of enhancing breast lesions. Daniel BL, Birdwell RL, Butts K, Nowels KW, Ikeda DM, Heiss SG, Cooper CR, Jeffrey SS, Dirbas FM, Herfkens RJ. J Magn Reson Imaging. 2001; 13 (6): 896-902
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL. Proc Natl Acad Sci U S A. 2001; 98 (19): 10869-74
• Characterization of breast lesion morphology with delayed 3DSSMT: an adjunct to dynamic breast MRI. Leong CS, Daniel BL, Herfkens RJ, Birdwell RL, Jeffrey SS, Ikeda DM, Sawyer-Glover AM, Glover GH. J Magn Reson Imaging. 2000; 11 (2): 87-96
• Controversies in sentinel lymph node biopsy for breast cancer. Jeffrey SS, Jones SB, Smith KL. Cancer Biother Radiopharm. 2000; 15 (3): 223-33
• Isosulfan blue affects pulse oximetry. Vokach-Brodsky L, Jeffrey SS, Lemmens HJ, Brock-Utne JG. Anesthesiology. 2000; 93 (4): 1002-3
• Management of breast cancer after Hodgkin's disease. Wolden SL, Hancock SL, Carlson RW, Goffinet DR, Jeffrey SS, Hoppe RT. J Clin Oncol. 2000; 18 (4): 765-72
• Molecular portraits of human breast tumours. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D. Nature. 2000; 406 (6797): 747-52
• Systematic variation in gene expression patterns in human cancer cell lines. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO. Nat Genet. 2000; 24 (3): 227-35
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D. Proc Natl Acad Sci U S A. 1999; 96 (16): 9212-7
• Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO. Nat Genet. 1999; 23 (1): 41-6
• Radiofrequency ablation of breast cancer: first report of an emerging technology. Jeffrey SS, Birdwell RL, Ikeda DM, Daniel BL, Nowels KW, Dirbas FM, Griffey SM. Arch Surg. 1999; 134 (10): 1064-8
• Three-dimensional shaded-surface rendering of MR images of the breast: technique, applications, and impact on surgical management of breast disease. Daniel BL, Jeffrey SS, Birdwell RL, Ikeda DM, Sawyer-Glover AM, Herfkens RJ. Radiographics. 1998 Mar-Apr; 18 (2): 483-96
• Breast disease: dynamic spiral MR imaging. Daniel BL, Yen YF, Glover GH, Ikeda DM, Birdwell RL, Sawyer-Glover AM, Black JW, Plevritis SK, Jeffrey SS, Herfkens RJ. Radiology. 1998; 209 (2): 499-509
• Breast lesion localization: a freehand, interactive MR imaging-guided technique. Daniel BL, Birdwell RL, Ikeda DM, Jeffrey SS, Black JW, Block WF, Sawyer-Glover AM, Glover GH, Herfkens RJ. Radiology. 1998; 207 (2): 455-63
• Preliminary experience with power Doppler imaging of solid breast masses. Birdwell RL, Ikeda DM, Jeffrey SS, Jeffrey RB. AJR Am J Roentgenol. 1997; 169 (3): 703-7
• Ultrasound tissue characterization of breast biopsy specimens: expanded study. Mortensen CL, Edmonds PD, Gorfu Y, Hill JR, Jensen JF, Schattner P, Shifrin LA, Valdes AD, Jeffrey SS, Esserman LJ. Ultrason Imaging. 1996; 18 (3): 215-30
• Value of sonographic identification of breast masses in excised specimens in the breast imaging department. Birdwell RL, Ikeda DM, Jeffrey SS. Breast Disease. 1996: 9 93-99
• Axillary lymphadenectomy for breast cancer without axillary drainage. Jeffrey SS, Goodson WH, Ikeda DM, Birdwell RL, Bogetz MS. Arch Surg. 1995; 130 (8): 909-12; discussion 912-3
• The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale FE, Goffinet DR. Cancer. 1995; 76 (2): 259-67
• Abdominal abscess. A surgical strategy. Glick PL, Pellegrini CA, Stein S, Way LW. Arch Surg. 1983; 118 (5): 646-50
• Cimetidine in the treatment of Zollinger-Ellison syndrome. Deveney CW, Stein S, Way LW. Am J Surg. 1983; 146 (1): 116-23
• Resection of gastrinomas. Deveney CW, Deveney KE, Stark D, Moss A, Stein S, Way LW. Ann Surg. 1983; 198 (4): 546-53
• Case report. Intramural hematoma of the cecum following blunt trauma. Jeffrey RB, Federle MP, Stein SM, Crass RA. J Comput Assist Tomogr. 1982; 6 (2): 404-5
• Resting state in normal and simian virus 40 transformed Chinese hamster lung cells. Martin RG, Stein S. Proc Natl Acad Sci U S A. 1976; 73 (5): 1655-9
• Glucose metabolism in Neisseria gonorrhoeae. Morse SA, Stein S, Hines J. J Bacteriol. 1974; 120 (2): 702-14
• Role for heme in mammalian protein synthesis: activation of an initiation factor. Raffel C, Stein S, Kaempfer R. Proc Natl Acad Sci U S A. 1974; 71 (10): 4020-24